MARATTO

article · Environmental Toxicology

Lemon Balm Attenuates Methotrexate‐Induced Testicular Damage Through Modulation of Oxidative Stress and p‐p38 <scp>MAPK</scp> Signaling

Abstract

This study investigated the protective effects of Lemon balm (Melissa officinalis) extract against methotrexate (MTX)-induced testicular toxicity in male Wistar rats. Thirty-two rats were divided into four groups: control, Lemon balm, MTX, and MTX + Lemon balm. MTX was administered intraperitoneally at 20 mg/kg on day 23, while Lemon balm was given orally at 100 mg/kg daily. The MTX-treated group showed significant reductions in body and testicular weight, sperm quality, and reproductive hormone levels [testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH)]. There was also a marked increase in oxidative stress markers [malondialdehyde (MDA), nitric oxide (NO)] and inflammation markers [tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, IL-1β, 8-hydroxy-2'-deoxyguanosine (8-OHdG)]. Immunohistochemical analysis revealed strong p-p38 mitogen-activated protein kinase (MAPK) expression in testicular tissues of the MTX group. Co-treatment with Lemon balm significantly improved sperm parameters and hormone levels while reducing oxidative and inflammatory responses, including marked downregulation of p-p38 MAPK expression. These findings suggest that Lemon balm extract may alleviate MTX-induced testicular toxicity through antioxidant, anti-inflammatory, and p-p38 MAPK pathway modulation.

Research topics

  • Chemotherapy-induced organ toxicity mitigation
  • Medicinal Plant Extracts Effects
  • Pomegranate: compositions and health benefits

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/tox.70099

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.